Cell Therapy
Autologous Cell Therapy for Critical Limb Ischemia
Recruiting0 awardsPhase 1 & 2
San Francisco, California
This trial will test the feasibility of using a mix of cells enriched for endothelial progenitor cells and multipotent adult hematopoietic stem/progenitor cells to treat peripheral arterial disease and critical limb ischemia.
Behavioral Intervention
Mobile App Health Data Collection for Peripheral Arterial Disease
Recruiting1 award
Gainesville, Florida
"This trial aims to test if using a mobile app to collect health data from older patients undergoing bypass surgery can help doctors better manage post-surgical symptoms and improve mobility and quality of life."
Popular Filters
Trials for PAD Patients
Bioresorbable Scaffold
Bioresorbable Arterial Scaffold for Peripheral Artery Disease
Recruiting1 award17 criteria
Montréal
This trial tests a new dissolvable stent for patients with severe leg artery blockages. The stent helps improve blood flow, releases medicine to prevent re-blockage, and then dissolves gradually. This could reduce pain and lower the risk of amputation. Bioabsorbable stents have been extensively evaluated in coronary artery disease but remain challenging and less studied in lower extremities.
Trials for Peripheral Artery Disease Patients
Bioresorbable Scaffold
Bioresorbable Arterial Scaffold for Peripheral Artery Disease
Recruiting1 award17 criteria
Montréal
This trial tests a new dissolvable stent for patients with severe leg artery blockages. The stent helps improve blood flow, releases medicine to prevent re-blockage, and then dissolves gradually. This could reduce pain and lower the risk of amputation. Bioabsorbable stents have been extensively evaluated in coronary artery disease but remain challenging and less studied in lower extremities.
Trials With No Placebo
Bioresorbable Scaffold
Bioresorbable Arterial Scaffold for Peripheral Artery Disease
Recruiting1 award17 criteria
Montréal
This trial tests a new dissolvable stent for patients with severe leg artery blockages. The stent helps improve blood flow, releases medicine to prevent re-blockage, and then dissolves gradually. This could reduce pain and lower the risk of amputation. Bioabsorbable stents have been extensively evaluated in coronary artery disease but remain challenging and less studied in lower extremities.
Peripheral Vascular Stent
MicroStent for Peripheral Arterial Disease
Recruiting1 award9 criteria
Birmingham, Alabama
This trial is testing a small tube-like device called the MicroStent® System, used along with a procedure that widens blood vessels, in patients with peripheral arterial disease who have blockages in the arteries below the knee. The stent helps keep the arteries open to ensure better blood flow. The Micro stent (MS) is a balloon expandable stent that allows the treatment of narrowings in distant and twisted coronary arteries.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.